Sun Pharma Launches First OTC Drug

India’s Sun Pharmaceutical recently rolled out its first OTC drug, antacid Pepmelt, as it leverages the consumer healthcare portfolio acquired in its Ranbaxy Laboratories buy.

Sun has acquired around 15 Ranbaxy OTC products, including big sellers Revital (health supplement) and Volini (analgesic), which made up over 20 percent of Ranbaxy’s sales.

Pepmelt, which involves melt-in-mouth granules, will compete with popular India antacids such as GSK's Eno and Abbott's Digene.

Read the Hindustan Times article